SGC agonist 2
SGC agonist 2 is a potent agonist of soluble guanylate cyclase (SGC) . Soluble guanylate cyclase is a key signal transduction enzyme in the NO-sGC-cGMP signaling pathway. SGC agonist 2 has the potential for the research of cardiovascular disease (heart failure, pulmonary hypertension, angina, myocardial infarction) and fibrotic diseases (renal fibrosis, systemic sclerosis) (extracted from patent WO2021219088A1, compound 031) [1].
Product Specifications
CAS Number
2735713-77-4
UNSPSC
12352005
Target
Guanylate Cyclase
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/sgc-agonist-2.html
Solubility
10 mM in DMSO
Smiles
O=C1[C@]2([H])C3=C(N1)NC(C(C4=C5)=NN(CC6=C(C=CC=C6)F)C4=NC=C5F)=NC3=NC(C2(C)C)=O
Molecular Formula
C23H17F2N7O2
Molecular Weight
461.42
References & Citations
[1]Fuyu Luo, et al. Pyrimidine tricyclic compounds and their applications. Patent WO2021219088A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Sec14l1 Rat shRNA Lentiviral Particle (Locus ID 360668)
Anti-Human CD192/CCR2 Reference Antibody (Minokitug, RUO)
Anti-Human CD192/CCR2 Reference Antibody (Minokitug, RUO)